Upgrade to SI Premium - Free Trial

OSR Holdings (OSRH)

0.39 -0.03 (7.14%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (11/17/25 *Est.)

Latest Headlines

CEO Statement to Shareholders June 3, 2026 12:05 PM - StreetInsider Form 8-K OSR Holdings, Inc. For: May 27 June 2, 2026 1:17 PM - SEC Filing OSR Holdings acquires VXM01 intellectual property for $30 million May 27, 2026 9:06 AM - StreetInsider OSR Holdings Acquires Full VXM01 Intellectual Property Portfolio in $30 Million Transaction May 27, 2026 9:06 AM - StreetInsider Form DEF 14A OSR Holdings, Inc. For: Jun 18 May 26, 2026 5:01 PM - SEC Filing Form 10-Q OSR Holdings, Inc. For: Mar 31 May 13, 2026 9:01 AM - SEC Filing OSR Holdings rules out reverse stock split amid nasdaq compliance deadline May 12, 2026 9:17 AM - StreetInsider CEO Statement to Shareholders May 12, 2026 9:16 AM - StreetInsider Form PRE 14A OSR Holdings, Inc. For: May 11 May 11, 2026 9:02 AM - SEC Filing Form 8-K/A OSR Holdings, Inc. For: Apr 29 May 6, 2026 5:26 PM - SEC Filing Presenting on Emerging Growth Conference 92 Day 2 on May 7; Register to live stream May 6, 2026 7:00 AM - Globe NewsWire Emerging Growth Research Issues Flash Report on OSR Holdings, Reaffirms Buy-Emerging Rating and $10.00 Price Target May 5, 2026 1:05 PM - StreetInsider Form 8-K OSR Holdings, Inc. For: Apr 29 April 30, 2026 1:07 PM - SEC Filing OSR Holdings to Present VXM01 Licensing Agreement at Emerging Growth Conference May 7, 2026 April 30, 2026 9:15 AM - StreetInsider OSR Holdings signs $815 million license deal for VXM01 drug candidate April 29, 2026 9:50 AM - StreetInsider OSR Holdings Executes Definitive $815 Million Global License Agreement for VXM01 with BCM Europe April 29, 2026 9:50 AM - StreetInsider Form SCHEDULE 13G OSR Holdings, Inc. Filed by: joint protein central inc. April 22, 2026 7:51 PM - SEC Filing Form 8-K OSR Holdings, Inc. For: Apr 16 April 22, 2026 5:28 PM - SEC Filing Form 3 OSR Holdings, Inc. For: Mar 26 Filed by: Kim Yeiseok April 16, 2026 10:10 AM - SEC Filing OSR Holdings retires $2.02 million in warrants through convertible note April 9, 2026 9:16 AM - StreetInsider Form 8-K OSR Holdings, Inc. For: Apr 07 April 9, 2026 9:16 AM - SEC Filing OSR Holdings Eliminates $2.02 Million Warrant Overhang with Premium-Priced Convertible Note April 9, 2026 9:15 AM - StreetInsider Form 8-K/A OSR Holdings, Inc. For: Mar 27 April 3, 2026 6:15 AM - SEC Filing Form 8-K OSR Holdings, Inc. For: Mar 27 April 2, 2026 3:46 PM - SEC Filing Form 10-K OSR Holdings, Inc. For: Dec 31 March 31, 2026 4:01 PM - SEC Filing Presenting on Emerging Growth Conference 91 Day 1 on April 1; Register to live stream March 31, 2026 7:00 AM - Globe NewsWire OSR Holdings to Update Investors at the Emerging Growth Conference on April 1, 2026 March 30, 2026 9:01 AM - StreetInsider Emerging Growth Research Issues Flash Report on OSR Holdings, Inc., Reaffirms Buy-Emerging Rating and $10.00 Price Target March 27, 2026 9:01 AM - StreetInsider OSR Holdings restructures $815 million VXM01 licensing deal March 23, 2026 8:40 AM - StreetInsider OSR Holdings Updates $815 Million VXM01 Licensing Deal Structure to Capture Value at Parent Level March 23, 2026 8:39 AM - StreetInsider OSR Holdings unit signs NDA with China's Sinopharm for glucose tech March 19, 2026 9:45 AM - StreetInsider Woori IO, an OSR Company, Signs NDA with Sinopharm for China Market and Global Multicenter Trials March 19, 2026 9:45 AM - PR NewsWire Woori IO, an OSR Company, Signs NDA with Sinopharm to Explore China Commercial Opportunities March 19, 2026 8:55 AM - StreetInsider Form 8-K OSR Holdings, Inc. For: Mar 13 March 16, 2026 8:01 AM - SEC Filing Form 8-K OSR Holdings, Inc. For: Mar 05 March 10, 2026 8:02 AM - SEC Filing Full Article List